SLC5A1 and heart failure: While some studies reported reduced heart failure incidence [142] and enhanced AMPK [139] with SGLT1 inhibition, others showed that AMPK activation resulted in increased SGLT1 expression, which can lead to hypertrophy and ischemia [143].